BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hashemi Goradel N, Najafi M, Salehi E, Farhood B, Mortezaee K. Cyclooxygenase-2 in cancer: A review. J Cell Physiol 2019;234:5683-99. [PMID: 30341914 DOI: 10.1002/jcp.27411] [Cited by in Crossref: 178] [Cited by in F6Publishing: 255] [Article Influence: 44.5] [Reference Citation Analysis]
Number Citing Articles
1 Leisz S, Klause CH, Vital Dos Santos T, Haenel P, Scheer M, Simmermacher S, Mawrin C, Strauss C, Scheller C, Rampp S. Vestibular Schwannoma Volume and Tumor Growth Correlates with Macrophage Marker Expression. Cancers 2022;14:4429. [DOI: 10.3390/cancers14184429] [Reference Citation Analysis]
2 Wach J, Güresir Á, Vatter H, Herrlinger U, Becker A, Toma M, Hölzel M, Güresir E. Low-Dose Acetylsalicylic Acid Treatment in Non-Skull-Base Meningiomas: Impact on Tumor Proliferation and Seizure Burden. Cancers 2022;14:4285. [DOI: 10.3390/cancers14174285] [Reference Citation Analysis]
3 Hidalgo-ríos S, Carrillo-garcía J, Moura DS, Stacchiotti S, López-pousa A, Redondo A, Italiano A, Gutiérrez A, Grignani G, Hindi N, López-guerrero J, Muro XGD, Trufero JM, Palmerini E, García AS, Bernabeu D, Le Cesne A, Casali PG, Blay J, Cruz Jurado J, Martin-broto J. Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib. Cancers 2022;14:4186. [DOI: 10.3390/cancers14174186] [Reference Citation Analysis]
4 Lian S, Lin X, Zhan F, Shen X, Liang Y, Li C. Transcriptome Analysis Reveals the Multiple Functions of pBD2 in IPEC-J2 Cells against E. coli. IJMS 2022;23:9754. [DOI: 10.3390/ijms23179754] [Reference Citation Analysis]
5 Lesko P, Chovanec M, Mego M. Biomarkers of disease recurrence in stage I testicular germ cell tumours. Nat Rev Urol 2022. [PMID: 36028719 DOI: 10.1038/s41585-022-00624-y] [Reference Citation Analysis]
6 Feng H, Chen G, Zhang Y, Guo M. Potential Multifunctional Bioactive Compounds from Dysosma versipellis Explored by Bioaffinity Ultrafiltration-HPLC/MS with Topo I, Topo II, COX-2 and ACE2. J Inflamm Res 2022;15:4677-92. [PMID: 35996684 DOI: 10.2147/JIR.S371830] [Reference Citation Analysis]
7 Garrido-Cano I, Adam-Artigues A, Lameirinhas A, Blandez JF, Candela-Noguera V, Rojo F, Zazo S, Madoz-Gúrpide J, Lluch A, Bermejo B, Sancenón F, Cejalvo JM, Martínez-Máñez R, Eroles P. miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies. Cancer Commun (Lond) 2022. [PMID: 35997029 DOI: 10.1002/cac2.12352] [Reference Citation Analysis]
8 de Freitas KS, da Silva LHD, Squarisi IS, de Souza Oliveira LT, Ribeiro AB, Alves BS, Esperandim TR, de Melo MRS, Ozelin SD, Lemes DC, Bastos JK, Veneziani RCS, Tavares DC. Red propolis exhibits chemopreventive effect associated with antiproliferative and anti-inflammatory activities. Toxicology Research 2022. [DOI: 10.1093/toxres/tfac049] [Reference Citation Analysis]
9 Abdelhaleem EF, Kassab AE, El-Nassan HB, Khalil OM. Recent advances in the development of celecoxib analogs as anticancer agents: A review. Arch Pharm (Weinheim) 2022;:e2200326. [PMID: 35996360 DOI: 10.1002/ardp.202200326] [Reference Citation Analysis]
10 Zhou J, Zeng W, Zeng Y, Li Y, Xiao Z, Zou J, Peng L, Xia J, Zeng X, Hussein AF. Anticancer and Anti-Inflammatory Mechanisms of NOSH-Aspirin and Its Biological Effects. Computational and Mathematical Methods in Medicine 2022;2022:1-7. [DOI: 10.1155/2022/4463294] [Reference Citation Analysis]
11 Lyndin M, Kravtsova O, Sikora K, Lyndina Y, Kuzenko Y, Awuah WA, Abdul-Rahman T, Hyriavenko N, Sikora V, Romaniuk A. COX2 Effects on endometrial carcinomas progression. Pathol Res Pract 2022;238:154082. [PMID: 36049440 DOI: 10.1016/j.prp.2022.154082] [Reference Citation Analysis]
12 Natewong S, Niwaspragrit C, Ratanachamnong P, Samatiwat P, Namchaiw P, Jaisin Y. Photo-Protective and Anti-Inflammatory Effects of Antidesma thwaitesianum Müll. Arg. Fruit Extract against UVB-Induced Keratinocyte Cell Damage. Molecules 2022;27:5034. [PMID: 35956984 DOI: 10.3390/molecules27155034] [Reference Citation Analysis]
13 Naderbar L, Pazhang Y, Rezaie J. Inhibiting AKT signaling pathway with cilostazol and meloxicam synergism for suppressing K562 cells in vitro. J Biochem Mol Toxicol 2022;:e23185. [PMID: 35920412 DOI: 10.1002/jbt.23185] [Reference Citation Analysis]
14 Trabalzini L, Ercoli J, Trezza A, Schiavo I, Macrì G, Moglia A, Spiga O, Finetti F. Pharmacological and In Silico Analysis of Oat Avenanthramides as EGFR Inhibitors: Effects on EGF-Induced Lung Cancer Cell Growth and Migration. IJMS 2022;23:8534. [DOI: 10.3390/ijms23158534] [Reference Citation Analysis]
15 Martínez-Puente DH, Garza-Morales R, Pérez-Trujillo JJ, Acosta FB, Villanueva-Olivo A, García-García A, Zavala-Flores LM, Rodríguez-Rocha H, Valdés J, Saucedo-Cárdenas O, Oca-Luna RM, Loera-Arias MJ. Enhanced antitumor activity induced by a DNA vaccine encoding E7 antigen fused to an ERAD-targeting sequence. J Drug Target 2022;:1-15. [PMID: 35896308 DOI: 10.1080/1061186X.2022.2107651] [Reference Citation Analysis]
16 Zhou P, Wu S, Huang D, Wang K, Su X, Yang R, Shao C, Wu J. Oral exposure to DEHP may stimulate prostatic hyperplasia associated with upregulation of COX-2 and L-PGDS expressions in male adult rats. Reprod Toxicol 2022;112:160-70. [PMID: 35905844 DOI: 10.1016/j.reprotox.2022.07.008] [Reference Citation Analysis]
17 Li J, Hu X, Zhang H, Peng Y, Li S, Xiong Y, Jiang W, Wang Z. N-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression. J Med Chem 2022. [PMID: 35868003 DOI: 10.1021/acs.jmedchem.2c00635] [Reference Citation Analysis]
18 Ismael AS, Amin NH, Elsaadi MT, Abdel-Rahman HM. Design, synthesis and mechanistic studies of novel imidazo[1,2-a]pyridines as anticancer agents. Bioorg Chem 2022;128:106042. [PMID: 35878430 DOI: 10.1016/j.bioorg.2022.106042] [Reference Citation Analysis]
19 Otley MOC, Sinal CJ. Adipocyte-Cancer Cell Interactions in the Bone Microenvironment. Front Endocrinol 2022;13:903925. [DOI: 10.3389/fendo.2022.903925] [Reference Citation Analysis]
20 Chan KF, Duarte JDG, Ostrouska S, Behren A. γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells. Front Immunol 2022;13:894315. [DOI: 10.3389/fimmu.2022.894315] [Reference Citation Analysis]
21 Saletti M, Maramai S, Reale A, Paolino M, Brogi S, Di Capua A, Cappelli A, Giorgi G, D'avino D, Rossi A, Ghelardini C, Di Cesare Mannelli L, Sardella R, Carotti A, Woelkart G, Klösch B, Bigogno C, Dondio G, Anzini M. Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant properties. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114615] [Reference Citation Analysis]
22 Liang X, Wang J, Liu Y, Wei L, Tian F, Sun J, Han G, Wang Y, Ding C, Guo Z. Polymorphisms of COX/PEG2 pathway-related genes are associated with the risk of lung cancer: A case–control study in China. International Immunopharmacology 2022;108:108763. [DOI: 10.1016/j.intimp.2022.108763] [Reference Citation Analysis]
23 Alqahtani AA, Attia GH, Elgamal A, Aleraky M, Youns M, Ibrahim AM, Abdou R, Shaikh IA, El Raey MA. Cytotoxic Activity of Zinc Oxide Nanoparticles Mediated by Euphorbia Retusa. Crystals 2022;12:903. [DOI: 10.3390/cryst12070903] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhou J, Wang L, Peng C, Peng F. Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology. Front Pharmacol 2022;13:886198. [DOI: 10.3389/fphar.2022.886198] [Reference Citation Analysis]
25 Swetha KL, Maravajjala KS, Li SD, Singh MS, Roy A. Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation. Drug Deliv Transl Res 2022. [PMID: 35697894 DOI: 10.1007/s13346-022-01194-7] [Reference Citation Analysis]
26 Maekawa N, Konnai S, Asano Y, Sajiki Y, Deguchi T, Okagawa T, Watari K, Takeuchi H, Takagi S, Hosoya K, Kim S, Ohta H, Kato Y, Suzuki Y, Murata S, Ohashi K. Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapy. Sci Rep 2022;12:9265. [PMID: 35665759 DOI: 10.1038/s41598-022-13484-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Huang H, Shao L, Chen Y, Han W, Zhou Y, Liu T, Gu J, Zhu H. Sequential Dual Delivery System Based on siCOX-2-Loaded Gold Nanostar and Thermal-Sensitive Liposomes Overcome Hypoxia-Mediated Multidrug Resistance in Tumors. Mol Pharm 2022. [PMID: 35639669 DOI: 10.1021/acs.molpharmaceut.2c00164] [Reference Citation Analysis]
28 Ortega MA, Fraile-martinez O, García-montero C, Borja-vergel S, Torres-carranza D, Pekarek L, Arribas CB, De León-luis JA, Sánchez-rojo C, Alvarez-mon MA, García-honduvilla N, Buján J, Coca S, Alvarez-mon M, Saez MA, Guijarro LG. Patients with Invasive Lobular Carcinoma Show a Significant Increase in IRS-4 Expression Compared to Infiltrative Ductal Carcinoma—A Histopathological Study. Medicina 2022;58:722. [DOI: 10.3390/medicina58060722] [Reference Citation Analysis]
29 Oh KK, Adnan M, Cho DH. Network pharmacology-based study to identify the significant pathways of Lentinula edodes against cancer. J Food Biochem 2022;:e14258. [PMID: 35633195 DOI: 10.1111/jfbc.14258] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ke S, Fang M, Li R, Wang J, Lu J. Downregulation of long noncoding RNA breast cancer anti-estrogen resistance 4 inhibits cell proliferation, invasion, and migration in esophageal squamous cell carcinoma by regulating the microRNA-181c-5p/LIM and SH3 protein 1 axis. Bioengineered 2022;13:12998-3010. [PMID: 35611706 DOI: 10.1080/21655979.2022.2060720] [Reference Citation Analysis]
31 Altıntop MD, Sever B, Akalın Çiftçi G, Ertorun İ, Alataş Ö, Özdemir A. A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition. Arch Pharm (Weinheim) 2022;:e2200136. [PMID: 35606682 DOI: 10.1002/ardp.202200136] [Reference Citation Analysis]
32 Le Chapelain O, Ho-Tin-Noé B. Intratumoral Platelets: Harmful or Incidental Bystanders of the Tumor Microenvironment? Cancers (Basel) 2022;14:2192. [PMID: 35565321 DOI: 10.3390/cancers14092192] [Reference Citation Analysis]
33 Du J, Feng J, Luo D, Peng L. Prognostic and Clinical Significance of COX-2 Overexpression in Laryngeal Cancer: A Meta-Analysis. Front Oncol 2022;12:854946. [DOI: 10.3389/fonc.2022.854946] [Reference Citation Analysis]
34 Herbein G. Tumors and Cytomegalovirus: An Intimate Interplay. Viruses 2022;14:812. [PMID: 35458542 DOI: 10.3390/v14040812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Masini MA, Bonetto V, Manfredi M, Pastò A, Barberis E, Timo S, Vanella VV, Robotti E, Masetto F, Andreoli F, Fiore A, Tavella S, Sica A, Donadelli M, Marengo E. Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis. Cell Mol Life Sci 2022;79:226. [PMID: 35391557 DOI: 10.1007/s00018-022-04243-z] [Reference Citation Analysis]
36 Moutabian H, Majdaeen M, Ghahramani-asl R, Yadollahi M, Gharepapagh E, Ataei G, Falahatpour Z, Bagheri H, Farhood B. A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02561-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, Wani S. Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol 2022;117:559-87. [PMID: 35354777 DOI: 10.14309/ajg.0000000000001680] [Cited by in Crossref: 9] [Article Influence: 9.0] [Reference Citation Analysis]
38 de la Cour CD, Dehlendorff C, von Buchwald C, Garset-zamani M, Grønhøj C, Carlander AF, Friis S, Kjaer SK. Non-aspirin NSAIDs and head and neck cancer mortality in a Danish nationwide cohort study. Cancer Epidemiology 2022;77:102121. [DOI: 10.1016/j.canep.2022.102121] [Reference Citation Analysis]
39 Jang JY, Sung B, Kim ND. Role of Induced Programmed Cell Death in the Chemopreventive Potential of Apigenin. Int J Mol Sci 2022;23:3757. [PMID: 35409117 DOI: 10.3390/ijms23073757] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
40 Kotta AS, Kelling AS, Corleto KA, Sun Y, Giles ED. Ghrelin and Cancer: Examining the Roles of the Ghrelin Axis in Tumor Growth and Progression. Biomolecules 2022;12:483. [DOI: 10.3390/biom12040483] [Reference Citation Analysis]
41 Huang HM, Huang XY, Wu SP, Chen CK, He XH, Zhang YF. Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1-AKT pathway. Cell Mol Biol Lett 2022;27:28. [PMID: 35305553 DOI: 10.1186/s11658-022-00324-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Zhang D, Nie J, Wang D, Wu H, Sun L, Wang X, Wu J. Engineering a multi-target therapy nanoplatform against tumor growth and metastasis via a novel NSAID-Pt(IV) prodrug. Chem Commun (Camb) 2022;58:3803-6. [PMID: 35229844 DOI: 10.1039/d1cc06385e] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Yang S, Cai C, Wang H, Ma X, Shao A, Sheng J, Yu C. Drug delivery strategy in hepatocellular carcinoma therapy. Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-021-00796-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
44 Jiang J, Yang Z, Hou G, Yao X, Jiang J. The potential mechanism of Chebulae Fructus in the treatment of hepatocellular carcinoma on the basis of network pharmacology. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100701] [Reference Citation Analysis]
45 Cátala-valentín AR, Almeda J, Bernard JN, Cole AM, Cole AL, Moore SD, Andl CD. E-Cigarette Aerosols Promote Oral S. aureus Colonization by Delaying an Immune Response and Bacterial Clearing. Cells 2022;11:773. [DOI: 10.3390/cells11050773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Haase-Kohn C, Laube M, Donat CK, Belter B, Pietzsch J. CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma Cells. Cells 2022;11:749. [PMID: 35203404 DOI: 10.3390/cells11040749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Guangshun S, Guoqiang S, Xin C, Xiangyi K, Wubin Z, Zhitao L, Zhiying Z, Hongyong C, Chengyu L, Yongxiang X, Weiwei T, Kanjoormana Aryan M. Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/4598573] [Reference Citation Analysis]
48 Liu Y, Wang X, Zhu Y, Cao Y, Wang L, Li F, Zhang Y, Li Y, Zhang Z, Luo J, Deng X, Peng C, Wei G, Chen H, Shen B. The CTCF/LncRNA‐PACERR complex recruits E1A binding protein p300 to induce pro‐tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.654] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
49 Bosch DJ, Nieuwenhuijs-Moeke GJ, van Meurs M, Abdulahad WH, Struys MMRF. Immune Modulatory Effects of Nonsteroidal Anti-inflammatory Drugs in the Perioperative Period and Their Consequence on Postoperative Outcome. Anesthesiology 2022. [PMID: 35180291 DOI: 10.1097/ALN.0000000000004141] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Ma J, Zhang C, Liang W, Li L, Du J, Pan C, Chen B, Chen Y, Wang Y. ω-3 and ω-6 Polyunsaturated Fatty Acids Regulate the Proliferation, Invasion and Angiogenesis of Gastric Cancer Through COX/PGE Signaling Pathway. Front Oncol 2022;12:802009. [DOI: 10.3389/fonc.2022.802009] [Reference Citation Analysis]
51 Branković J, Krokidis MG, Dousi I, Papadopoulos K, Petrović ZD, Petrović VP. Antioxidant and cytotoxic activities of selected salicylidene imines: experimental and computational study. Mol Divers 2022. [PMID: 35147861 DOI: 10.1007/s11030-021-10370-9] [Reference Citation Analysis]
52 Priya D, Gopinath P, Dhivya LS, Vijaybabu A, Haritha M, Palaniappan S, Kathiravan MK. Structural Insights into Pyrazoles as Agents against Anti‐inflammatory and Related Disorders. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202104429] [Reference Citation Analysis]
53 Niklander SE. Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential. Front Oral Health 2021;2:642238. [PMID: 35047997 DOI: 10.3389/froh.2021.642238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
54 Martínez-Iglesias O, Carrera I, Naidoo V, Cacabelos R. AntiGan: An Epinutraceutical Bioproduct with Antitumor Properties in Cultured Cell Lines. Life (Basel) 2022;12:97. [PMID: 35054489 DOI: 10.3390/life12010097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Hu L, Fan M, Shi S, Song X, Wang F, He H, Qi B. Dual target inhibitors based on EGFR: Promising anticancer agents for the treatment of cancers (2017-). Eur J Med Chem 2022;227:113963. [PMID: 34749202 DOI: 10.1016/j.ejmech.2021.113963] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
56 Seyyedi R, Talebpour Amiri F, Farzipour S, Mihandoust E, Hosseinimehr SJ. Mefenamic acid as a promising therapeutic medicine against colon cancer in tumor-bearing mice. Med Oncol 2022;39:18. [PMID: 34982268 DOI: 10.1007/s12032-021-01618-3] [Reference Citation Analysis]
57 Dibia KT, Igbokwe PK, Ezemagu GI, Asadu CO. Exploration of the quantitative Structure-Activity relationships for predicting Cyclooxygenase-2 inhibition bioactivity by Machine learning approaches. Results in Chemistry 2022;4:100272. [DOI: 10.1016/j.rechem.2021.100272] [Reference Citation Analysis]
58 Ahmadi M, Bekeschus S, Weltmann K, von Woedtke T, Wende K. Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors. RSC Med Chem . [DOI: 10.1039/d1md00280e] [Reference Citation Analysis]
59 Ebrahimi N, Adelian S, Shakerian S, Afshinpour M, Chaleshtori SR, Rostami N, Hamblin MR, Aref AR. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: implications for inflammation and cancer therapy. Cytokine & Growth Factor Reviews 2022. [DOI: 10.1016/j.cytogfr.2022.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
60 Jaragh-alhadad LA, Harisa GI, Alanazi FK. Development of nimesulide analogs as a dual inhibitor targeting tubulin and HSP27 for treatment of female cancers. Journal of Molecular Structure 2022;1248:131479. [DOI: 10.1016/j.molstruc.2021.131479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
61 Luo T, Jiang JG. Anticancer Effects and Molecular Target of Theaflavins from Black Tea Fermentation in Vitro and in Vivo. J Agric Food Chem 2021;69:15052-65. [PMID: 34878780 DOI: 10.1021/acs.jafc.1c05313] [Reference Citation Analysis]
62 Xu W, Li B, Xu M, Yang T, Hao X. Traditional Chinese medicine for precancerous lesions of gastric cancer: A review. Biomed Pharmacother 2021;146:112542. [PMID: 34929576 DOI: 10.1016/j.biopha.2021.112542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
63 Cui S, Yu Y, Zhan T, Gao Y, Zhang J, Zhang L, Ge Z, Liu W, Zhang C, Zhuang S. Carcinogenic Risk of 2,6-Di-tert-Butylphenol and Its Quinone Metabolite 2,6-DTBQ Through Their Interruption of RARβ: In Vivo, In Vitro, and In Silico Investigations. Environ Sci Technol 2021. [PMID: 34927421 DOI: 10.1021/acs.est.1c06866] [Reference Citation Analysis]
64 Stransky N, Ruth P, Schwab M, Löffler MW. Can Any Drug Be Repurposed for Cancer Treatment? A Systematic Assessment of the Scientific Literature. Cancers (Basel) 2021;13:6236. [PMID: 34944859 DOI: 10.3390/cancers13246236] [Reference Citation Analysis]
65 Baecker D, Sagasser J, Karaman S, Hörmann AA, Gust R. Development of methylated cobalt-alkyne complexes with selective cytotoxicity against COX-positive cancer cell lines. Arch Pharm (Weinheim) 2021;:e2100408. [PMID: 34893997 DOI: 10.1002/ardp.202100408] [Reference Citation Analysis]
66 Sanjeewa KKA, Herath KHINM, Yang HW, Choi CS, Jeon YJ. Anti-Inflammatory Mechanisms of Fucoidans to Treat Inflammatory Diseases: A Review. Mar Drugs 2021;19:678. [PMID: 34940677 DOI: 10.3390/md19120678] [Reference Citation Analysis]
67 Hermawan A, Putri H. Systematic analysis of potential targets of the curcumin analog pentagamavunon-1 (PGV-1) in overcoming resistance of glioblastoma cells to bevacizumab. Saudi Pharm J 2021;29:1289-302. [PMID: 34819791 DOI: 10.1016/j.jsps.2021.09.015] [Reference Citation Analysis]
68 Ramos-Inza S, Ruberte AC, Sanmartín C, Sharma AK, Plano D. NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future. J Med Chem 2021;64:16380-421. [PMID: 34784195 DOI: 10.1021/acs.jmedchem.1c01460] [Reference Citation Analysis]
69 Fleischmann M, Chatzikonstantinou G, Fokas E, Wichmann J, Christiansen H, Strebhardt K, Rödel C, Tselis N, Rödel F. Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer. Cancers (Basel) 2021;13:5748. [PMID: 34830902 DOI: 10.3390/cancers13225748] [Reference Citation Analysis]
70 Subkorn P, Norkaew C, Deesrisak K, Tanyong D. Punicalagin, a pomegranate compound, induces apoptosis and autophagy in acute leukemia. PeerJ 2021;9:e12303. [PMID: 34760363 DOI: 10.7717/peerj.12303] [Reference Citation Analysis]
71 Padmavathi G, Monisha J, Bordoloi D, Banik K, Roy NK, Girisa S, Singh AK, Longkumer I, Baruah MN, Kunnumakkara AB. Tumor necrosis factor-α induced protein 8 (TNFAIP8/TIPE) family is differentially expressed in oral cancer and regulates tumorigenesis through Akt/mTOR/STAT3 signaling cascade. Life Sci 2021;287:120118. [PMID: 34740574 DOI: 10.1016/j.lfs.2021.120118] [Reference Citation Analysis]
72 Qiao Y, Qin Y, Liu L, Chen X, Li Y, Li Q. An Investigation into the Interaction between Double Hydroxide-Based Antioxidant Benzophenone Derivatives and Cyclooxygenase 2. Molecules 2021;26:6622. [PMID: 34771031 DOI: 10.3390/molecules26216622] [Reference Citation Analysis]
73 Zhou P, Shi W, He XY, Du QY, Wang F, Guo J. Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics. Pharm Biol 2021;59:1480-9. [PMID: 34714209 DOI: 10.1080/13880209.2021.1992448] [Reference Citation Analysis]
74 Corsale AM, Di Simone M, Lo Presti E, Picone C, Dieli F, Meraviglia S. Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions? Cells 2021;10:2896. [PMID: 34831116 DOI: 10.3390/cells10112896] [Reference Citation Analysis]
75 Duan XY, Ma RJ, Hsiao CD, Jiang ZZ, Zhang LY, Zhang Y, Liu KC. Tripterygium wilfordii multiglycoside-induced hepatotoxicity via inflammation and apoptosis in zebrafish. Chin J Nat Med 2021;19:750-7. [PMID: 34688465 DOI: 10.1016/S1875-5364(21)60078-X] [Reference Citation Analysis]
76 Omidkhah N, Ghodsi R. NO-HDAC dual inhibitors. Eur J Med Chem 2022;227:113934. [PMID: 34700268 DOI: 10.1016/j.ejmech.2021.113934] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Zhang Y, Long J, Ren J, Huang X, Zhong P, Wang B. Potential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects. Front Oncol 2021;11:731441. [PMID: 34646772 DOI: 10.3389/fonc.2021.731441] [Reference Citation Analysis]
78 Zahedi T, Colagar AH, Mahmoodzadeh H, Raoof JB. Missense mutations involvement in COX-2 structure, and protein-substrate binding affinity: in-silico study. Nucleosides Nucleotides Nucleic Acids 2021;40:1125-43. [PMID: 34632961 DOI: 10.1080/15257770.2021.1983826] [Reference Citation Analysis]
79 De Vita S, Chini MG, Saviano G, Finamore C, Festa C, Lauro G, De Marino S, Russo R, Avagliano C, Casapullo A, Calignano A, Bifulco G, Iorizzi M. Biological Profile of Two Gentiana lutea L. Metabolites Using Computational Approaches and In Vitro Tests. Biomolecules 2021;11:1490. [PMID: 34680124 DOI: 10.3390/biom11101490] [Reference Citation Analysis]
80 Liu X, Bian L, Duan X, Zhuang X, Sui Y, Yang L. Alantolactone: A sesquiterpene lactone with diverse pharmacological effects. Chem Biol Drug Des 2021;98:1131-45. [PMID: 34624172 DOI: 10.1111/cbdd.13972] [Reference Citation Analysis]
81 Weng Y, Xiang J, Le W, Mao Y. Role of MicroRNA-101 on Proliferation and Migration of Prostate Cancer Cells. j biomater tissue eng 2021;11:2076-80. [DOI: 10.1166/jbt.2021.2789] [Reference Citation Analysis]
82 Oğuz SŞ, Kutman GHK, Oğuz K. The Anesthetic Modality but Not the Mode of Delivery Seem to Modulate the Methylation Status of Cyclooxygenase-2 Promoter of the Newborns. Am J Perinatol 2021. [PMID: 34587635 DOI: 10.1055/s-0041-1735898] [Reference Citation Analysis]
83 Berbecka M, Forma A, Baj J, Furtak-Niczyporuk M, Maciejewski R, Sitarz R. A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy. J Clin Med 2021;10:4443. [PMID: 34640461 DOI: 10.3390/jcm10194443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Huang B, Yan X, Li Y. Cancer Stem Cell for Tumor Therapy. Cancers (Basel) 2021;13:4814. [PMID: 34638298 DOI: 10.3390/cancers13194814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
85 Zhang X, Du L, Zhang J, Li C, Zhang J, Lv X. Hordenine Protects Against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Inflammation. Front Pharmacol 2021;12:712232. [PMID: 34539399 DOI: 10.3389/fphar.2021.712232] [Reference Citation Analysis]
86 de la Cour CD, von Buchwald C, Dehlendorff C, Garset-Zamani M, Grønhøj C, Carlander AF, Friis S, Kjaer SK. Low-dose aspirin use and mortality risk in patients with head and neck cancer: A nationwide cohort study of 10 770 patients. Int J Cancer 2021. [PMID: 34536296 DOI: 10.1002/ijc.33814] [Reference Citation Analysis]
87 Wang M, Chaudhuri R, Ong WWS, Sintim HO. c-di-GMP Induces COX-2 Expression in Macrophages in a STING-Independent Manner. ACS Chem Biol 2021;16:1663-70. [PMID: 34478263 DOI: 10.1021/acschembio.1c00342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Liu X, Yamaguchi K, Takane K, Zhu C, Hirata M, Hikiba Y, Maeda S, Furukawa Y, Ikenoue T. Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis. PLoS One 2021;16:e0257090. [PMID: 34516556 DOI: 10.1371/journal.pone.0257090] [Reference Citation Analysis]
89 Lasagna M, Ventura C, Hielpos MS, Mardirosian MN, Martín G, Miret N, Randi A, Núñez M, Cocca C. Endocrine disruptor chlorpyrifos promotes migration, invasion, and stemness phenotype in 3D cultures of breast cancer cells and induces a wide range of pathways involved in cancer progression. Environ Res 2021;204:111989. [PMID: 34506784 DOI: 10.1016/j.envres.2021.111989] [Reference Citation Analysis]
90 Satija G, Sharma B, Madan A, Iqubal A, Shaquiquzzaman M, Akhter M, Parvez S, Khan MA, Alam MM. Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets. Journal of Heterocyclic Chem 2022;59:22-66. [DOI: 10.1002/jhet.4355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
91 Peng W, Zhang ML, Zhang J, Chen G. Potential role of hydrogen sulfide in central nervous system tumors: a narrative review. Med Gas Res 2022;12:6-9. [PMID: 34472496 DOI: 10.4103/2045-9912.324590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Suryanti S, Agustina H, Aziz A, Yulianti H, Suryawathy B, Putri L. High Immunoexpression of COX-2 as a Metastatic Risk Factor in ccRCC without PD-L1 Involvement. Res Rep Urol 2021;13:623-30. [PMID: 34466408 DOI: 10.2147/RRU.S324510] [Reference Citation Analysis]
93 Emanuele Liardo RL, Borzì AM, Spatola C, Martino B, Privitera G, Basile F, Biondi A, Vacante M. Effects of infections on the pathogenesis of cancer. Indian J Med Res 2021;153:431-45. [PMID: 34380789 DOI: 10.4103/ijmr.IJMR_339_19] [Reference Citation Analysis]
94 Alonso-Miguel D, Valdivia G, García-San José P, Alonso-Diez Á, Clares I, Portero M, Peña L, Pérez-Alenza MD. Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase-2 inhibitor and toceranib phosphate. Vet Comp Oncol 2021. [PMID: 34390295 DOI: 10.1111/vco.12760] [Reference Citation Analysis]
95 Li W, Zhang Z, Wang B, Liang N, Zhou Q, Long S. MicroRNA and cyclooxygenase-2 in breast cancer. Clin Chim Acta 2021;522:36-44. [PMID: 34389281 DOI: 10.1016/j.cca.2021.08.007] [Reference Citation Analysis]
96 Sluter MN, Hou R, Li L, Yasmen N, Yu Y, Liu J, Jiang J. EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics. J Med Chem 2021;64:11816-36. [PMID: 34352171 DOI: 10.1021/acs.jmedchem.1c00816] [Reference Citation Analysis]
97 Caldas AR, Catita J, Machado R, Ribeiro A, Cerqueira F, Horta B, Medeiros R, Lúcio M, Lopes CM. Omega-3- and Resveratrol-Loaded Lipid Nanosystems for Potential Use as Topical Formulations in Autoimmune, Inflammatory, and Cancerous Skin Diseases. Pharmaceutics 2021;13:1202. [PMID: 34452163 DOI: 10.3390/pharmaceutics13081202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Zhang Y, Chen H, Chen S, Li Z, Chen J, Li W. The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis. Oncoimmunology 2021;10:1957605. [PMID: 34377596 DOI: 10.1080/2162402X.2021.1957605] [Reference Citation Analysis]
99 Tomita K, Nagasawa T, Kuwahara Y, Torii S, Igarashi K, Roudkenar MH, Roushandeh AM, Kurimasa A, Sato T. MiR-7-5p Is Involved in Ferroptosis Signaling and Radioresistance Thru the Generation of ROS in Radioresistant HeLa and SAS Cell Lines. Int J Mol Sci 2021;22:8300. [PMID: 34361070 DOI: 10.3390/ijms22158300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Jung YY, Kim C, Ha IJ, Lee SG, Lee J, Um JY, Ahn KS. Pyrimethamine Modulates Interplay between Apoptosis and Autophagy in Chronic Myelogenous Leukemia Cells. Int J Mol Sci 2021;22:8147. [PMID: 34360911 DOI: 10.3390/ijms22158147] [Reference Citation Analysis]
101 Moratin J, Mock A, Obradovic S, Metzger K, Flechtenmacher C, Zaoui K, Fröhling S, Jäger D, Krauss J, Hoffmann J, Freier K, Horn D, Hess J, Freudlsperger C. Digital Pathology Scoring of Immunohistochemical Staining Reliably Identifies Prognostic Markers and Anatomical Associations in a Large Cohort of Oral Cancers. Front Oncol 2021;11:712944. [PMID: 34395287 DOI: 10.3389/fonc.2021.712944] [Reference Citation Analysis]
102 Sobolewski C, Legrand N. Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib. Biomolecules 2021;11:1049. [PMID: 34356673 DOI: 10.3390/biom11071049] [Reference Citation Analysis]
103 Liu Z, Sun J, Liang T, Huang X. Increased expression of cyclooxygenase-2 in synovium tissues and synovial fluid from patients with knee osteoarthritis is associated with downregulated microRNA-758-3p expression. Exp Ther Med 2021;22:1001. [PMID: 34345283 DOI: 10.3892/etm.2021.10433] [Reference Citation Analysis]
104 Lavy M, Gauttier V, Poirier N, Barillé-Nion S, Blanquart C. Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities. Front Immunol 2021;12:702785. [PMID: 34276698 DOI: 10.3389/fimmu.2021.702785] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
105 He Y, Ayansola H, Hou Q, Liao C, Lei J, Lai Y, Jiang Q, Masatoshi H, Zhang B. Genistein Inhibits Colonic Goblet Cell Loss and Colorectal Inflammation Induced by Salmonella Typhimurium Infection. Mol Nutr Food Res 2021;65:e2100209. [PMID: 34146390 DOI: 10.1002/mnfr.202100209] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
106 Xu F, Zhang Z, Zhao Y, Zhou Y, Pei H, Bai L. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma. Gene 2021;795:145804. [PMID: 34175402 DOI: 10.1016/j.gene.2021.145804] [Reference Citation Analysis]
107 Wang X, Zhu G, Yang H, Gao R, Wu Z, Zhang Y, Zhu X, Zhang X, Li J. An Investigation of the Antigastric Cancer Effect in Tumor Microenvironment of Radix Rhei Et Rhizome: A Network Pharmacology Study. Evid Based Complement Alternat Med 2021;2021:9913952. [PMID: 34257692 DOI: 10.1155/2021/9913952] [Reference Citation Analysis]
108 Lüke F, Harrer DC, Menhart K, Wolff D, Holler E, Hellwig D, Herr W, Grube M, Vogelhuber M, Reichle A, Heudobler D. Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin's Disease. Front Pharmacol 2021;12:599561. [PMID: 34220492 DOI: 10.3389/fphar.2021.599561] [Reference Citation Analysis]
109 Kishimoto K, Kanazawa K, Nomura M, Tanaka T, Shigemoto-Kuroda T, Fukui K, Miura K, Kurosawa K, Kawai M, Kato H, Terasaki K, Sakamoto Y, Yamashita Y, Sato I, Tanuma N, Tamai K, Kitabayashi I, Matsuura K, Watanabe T, Yasuda J, Tsuji H, Shima H. Ppp6c deficiency accelerates K-rasG12D -induced tongue carcinogenesis. Cancer Med 2021;10:4451-64. [PMID: 34145991 DOI: 10.1002/cam4.3962] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Adeluola A, Zulfiker AHM, Brazeau D, Amin ARMR. Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: An update with promising analogues. Eur J Pharmacol 2021;906:174266. [PMID: 34146588 DOI: 10.1016/j.ejphar.2021.174266] [Reference Citation Analysis]
111 Gómez-Valenzuela F, Escobar E, Pérez-Tomás R, Montecinos VP. The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition. Front Oncol 2021;11:686792. [PMID: 34178680 DOI: 10.3389/fonc.2021.686792] [Reference Citation Analysis]
112 Pang L, Shah H, Qian S, Sathish V. Iminodibenzyl redirected cyclooxygenase-2 catalyzed dihomo-γ-linolenic acid peroxidation pattern in lung cancer. Free Radic Biol Med 2021;172:167-80. [PMID: 34102280 DOI: 10.1016/j.freeradbiomed.2021.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
113 Lv P, Man S, Xie L, Ma L, Gao W. Pathogenesis and therapeutic strategy in platinum resistance lung cancer. Biochim Biophys Acta Rev Cancer 2021;1876:188577. [PMID: 34098035 DOI: 10.1016/j.bbcan.2021.188577] [Reference Citation Analysis]
114 Fan J, Yang Y, Qian JK, Zhang X, Ji JQ, Zhang L, Li SZ, Yuan F. Aberrant Expression of PAFAH1B3 Affects Proliferation and Apoptosis in Osteosarcoma. Front Oncol 2021;11:664478. [PMID: 34136395 DOI: 10.3389/fonc.2021.664478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Karthika C, Hari B, Rahman MH, Akter R, Najda A, Albadrani GM, Sayed AA, Akhtar MF, Abdel-Daim MM. Multiple strategies with the synergistic approach for addressing colorectal cancer. Biomed Pharmacother 2021;140:111704. [PMID: 34082400 DOI: 10.1016/j.biopha.2021.111704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
116 Cao Y, Jia X, Huang Y, Wang J, Lu C, Yuan X, Xu J, Zhu H. Vitamin D stimulates miR-26b-5p to inhibit placental COX-2 expression in preeclampsia. Sci Rep 2021;11:11168. [PMID: 34045549 DOI: 10.1038/s41598-021-90605-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
117 Harati R, Mabondzo A, Tlili A, Khoder G, Mahfood M, Hamoudi R. Combinatorial targeting of microRNA-26b and microRNA-101 exerts a synergistic inhibition on cyclooxygenase-2 in brain metastatic triple-negative breast cancer cells. Breast Cancer Res Treat 2021;187:695-713. [PMID: 34041621 DOI: 10.1007/s10549-021-06255-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Lee HJ, Kim SR, Jung YJ, Han JA. Cyclooxygenase-2 induces neoplastic transformation by inhibiting p53-dependent oncogene-induced senescence. Sci Rep 2021;11:9853. [PMID: 33972599 DOI: 10.1038/s41598-021-89220-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Rajapaksha AA, Fu YX, Guo WY, Liu SY, Li ZW, Xiong CQ, Yang WC, Yang GF. Review on the recent progress in the development of fluorescent probes targeting enzymes. Methods Appl Fluoresc 2021;9. [PMID: 33873170 DOI: 10.1088/2050-6120/abf988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
120 Mena J, Elgueta E, Espinola-Gonzales F, Cardenas H, Orihuela PA. Hydroethanolic Extracts of the Aristotelia Chilensis (Maqui) Berry Reduces Cellular Viability and Invasiveness in the Endometrial Cancer Cell Line Ishikawa. Integr Cancer Ther 2021;20:15347354211007560. [PMID: 33926283 DOI: 10.1177/15347354211007560] [Reference Citation Analysis]
121 Davern M, Donlon NE, Power R, Hayes C, King R, Dunne MR, Reynolds JV. The tumour immune microenvironment in oesophageal cancer. Br J Cancer 2021;125:479-94. [PMID: 33903730 DOI: 10.1038/s41416-021-01331-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
122 Wang Q, Xiao M, Wang D, Hou X, Gao J, Liu J, Liu J. In Situ Supramolecular Self‐Assembly of Pt(IV) Prodrug to Conquer Cisplatin Resistance. Adv Funct Mater 2021;31:2101826. [DOI: 10.1002/adfm.202101826] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
123 Watson J, Ninh MK, Ashford S, Cornett EM, Kaye AD, Urits I, Viswanath O. Anesthesia Medications and Interaction with Chemotherapeutic Agents. Oncol Ther 2021;9:121-38. [PMID: 33861416 DOI: 10.1007/s40487-021-00149-1] [Reference Citation Analysis]
124 Ollauri-Ibáñez C, Ayuso-Íñigo B, Pericacho M. Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization? Cancers (Basel) 2021;13:1552. [PMID: 33800564 DOI: 10.3390/cancers13071552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
125 Papayannakos CJ, DeVoti JA, Israr M, Alsudani H, Bonagura V, Steinberg BM. Extracellular vesicles produced by primary human keratinocytes in response to TLR agonists induce stimulus-specific responses in antigen-presenting cells. Cell Signal 2021;83:109994. [PMID: 33781846 DOI: 10.1016/j.cellsig.2021.109994] [Reference Citation Analysis]
126 Gong Z, Huang W, Wang B, Liang N, Long S, Li W, Zhou Q. Interplay between cyclooxygenase‑2 and microRNAs in cancer (Review). Mol Med Rep 2021;23:347. [PMID: 33760116 DOI: 10.3892/mmr.2021.11986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
127 Afzal SM, Vafa A, Rashid S, Shree A, Islam J, Ali N, Sultana S. Amelioration of N,N'-dimethylhydrazine induced colon toxicity by epigallocatechin gallate in Wistar rats. Hum Exp Toxicol 2021;40:1558-71. [PMID: 33754881 DOI: 10.1177/09603271211002884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Jing CY, Fu YP, Zhou C, Zhang MX, Yi Y, Huang JL, Gan W, Zhang J, Zheng SS, Zhang BH, Qiu SJ. Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis. Oncogene 2021;40:2910-22. [PMID: 33742120 DOI: 10.1038/s41388-021-01705-9] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
129 Lee J, Kim HS, Jangili P, Kang HG, Sharma A, Kim JS. Fluorescent Probe for Monitoring Hydrogen Peroxide in COX-2-Positive Cancer Cells. ACS Appl Bio Mater 2021;4:2073-9. [PMID: 35014334 DOI: 10.1021/acsabm.0c01135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
130 Amere Subbarao S. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting. Inflammopharmacology 2021;29:343-66. [PMID: 33723711 DOI: 10.1007/s10787-021-00796-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
131 Gregório H, Magalhães TR, Pires I, Prada J, Carvalho MI, Queiroga FL. The role of COX expression in the prognostication of overall survival of canine and feline cancer: A systematic review. Vet Med Sci 2021;7:1107-19. [PMID: 33751829 DOI: 10.1002/vms3.460] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Feng B, Hess J. Immune-Related Mutational Landscape and Gene Signatures: Prognostic Value and Therapeutic Impact for Head and Neck Cancer. Cancers (Basel) 2021;13:1162. [PMID: 33800421 DOI: 10.3390/cancers13051162] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
133 Gipsyianti N, Aziz A, Hernowo BS, Usman HA. High Expression of COX-2 Associated with the Depth of Invasion on Acral Melanoma by Increasing TGF-β1. Clin Cosmet Investig Dermatol 2021;14:209-16. [PMID: 33688233 DOI: 10.2147/CCID.S285564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Gonçalves S, Yin K, Ito Y, Chan A, Olan I, Gough S, Cassidy L, Serrao E, Smith S, Young A, Narita M, Hoare M. COX2 regulates senescence secretome composition and senescence surveillance through PGE2. Cell Rep 2021;34:108860. [PMID: 33730589 DOI: 10.1016/j.celrep.2021.108860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
135 Pu D, Yin L, Huang L, Qin C, Zhou Y, Wu Q, Li Y, Zhou Q, Li L. Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer. Front Oncol 2021;11:637504. [PMID: 33718229 DOI: 10.3389/fonc.2021.637504] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
136 Chan L, Chen X, Gao P, Xie J, Zhang Z, Zhao J, Chen T. Coordination-Driven Enhancement of Radiosensitization by Black Phosphorus via Regulating Tumor Metabolism. ACS Nano 2021;15:3047-60. [PMID: 33507069 DOI: 10.1021/acsnano.0c09454] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 21.0] [Reference Citation Analysis]
137 Suriyo T, Fuangthong M, Artpradit C, Ungtrakul T, Sricharunrat T, Taha F, Satayavivad J. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells. Eur J Pharmacol 2021;897:173960. [PMID: 33617828 DOI: 10.1016/j.ejphar.2021.173960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Ooi TC, Yaacob M, Rajab NF, Shahar S, Sharif R. The stingless bee honey protects against hydrogen peroxide-induced oxidative damage and lipopolysaccharide-induced inflammation in vitro. Saudi J Biol Sci 2021;28:2987-94. [PMID: 34025176 DOI: 10.1016/j.sjbs.2021.02.039] [Reference Citation Analysis]
139 Kohli K, Pillarisetty VG, Kim TS. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther 2021. [PMID: 33603130 DOI: 10.1038/s41417-021-00303-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
140 Schultz F, Osuji OF, Wack B, Anywar G, Garbe LA. Antiinflammatory Medicinal Plants from the Ugandan Greater Mpigi Region Act as Potent Inhibitors in the COX-2/PGH2 Pathway. Plants (Basel) 2021;10:351. [PMID: 33673238 DOI: 10.3390/plants10020351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
141 Vogl M, Rosenmayr A, Bohanes T, Scheed A, Brndiar M, Stubenberger E, Ghanim B. Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation. Cancers (Basel) 2021;13:658. [PMID: 33562138 DOI: 10.3390/cancers13040658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
142 Mabrouk AA, Tadros MI, El-refaie WM. Improving the efficacy of Cyclooxegenase-2 inhibitors in the management of oral cancer: Insights into the implementation of nanotechnology and mucoadhesion. Journal of Drug Delivery Science and Technology 2021;61:102240. [DOI: 10.1016/j.jddst.2020.102240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
143 Weng CY, Kao CX, Chang TS, Huang YH. Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance. Int J Mol Sci 2021;22:1258. [PMID: 33514004 DOI: 10.3390/ijms22031258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Mintz J, Vedenko A, Rosete O, Shah K, Goldstein G, Hare JM, Ramasamy R, Arora H. Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics. Vaccines (Basel) 2021;9:94. [PMID: 33513777 DOI: 10.3390/vaccines9020094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
145 Chen T, Yang P, Jia Y. Molecular mechanisms of astragaloside‑IV in cancer therapy (Review). Int J Mol Med 2021;47:13. [PMID: 33448320 DOI: 10.3892/ijmm.2021.4846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
146 Verma U, Gautam M, Parmar B, Khaire K, Wishart DS, Balakrishnan S. New insights into the obligatory nature of cyclooxygenase-2 and PGE2 during early chick embryogenesis. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158889. [PMID: 33454433 DOI: 10.1016/j.bbalip.2021.158889] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Lopes C, Pereira C, Farinha M, Medeiros R, Dinis-Ribeiro M. Genetic Variations in Prostaglandin E2 Pathway Identified as Susceptibility Biomarkers for Gastric Cancer in an Intermediate Risk European Country. Int J Mol Sci. 2021;22. [PMID: 33440718 DOI: 10.3390/ijms22020648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Zhang WJ. Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy. Purinergic Signal 2021;17:151-62. [PMID: 33420658 DOI: 10.1007/s11302-020-09761-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Zhou Q, Jin P, Liu J, Li S, Liu W, Xi S. Arsenic-induced HER2 promotes proliferation, migration and angiogenesis of bladder epithelial cells via activation of multiple signaling pathways in vitro and in vivo. Science of The Total Environment 2021;753:141962. [DOI: 10.1016/j.scitotenv.2020.141962] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
150 Marinov L, Georgieva A, Voynikov Y, Toshkova R, Nikolova I, Malchev M. Cytotoxic and antiproliferative effects of the nonsteroidal anti-inflammatory drug diclofenac in human tumour cell lines. Biotechnology & Biotechnological Equipment 2021;35:1118-26. [DOI: 10.1080/13102818.2021.1953401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
151 Mitchell JA, Kirkby NS, Ahmetaj-shala B, Armstrong PC, Crescente M, Ferreira P, Lopes Pires ME, Vaja R, Warner TD. Cyclooxygenases and the cardiovascular system. Pharmacology & Therapeutics 2021;217:107624. [DOI: 10.1016/j.pharmthera.2020.107624] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
152 Abdellateif MS, Salem SE, Badr DM, Shaarawy S, Hussein MM, Zekri AN, Fouad MA. The Prognostic Significance of 5-Fluorouracil Induced Inflammation and Immuno-Modulation in Colorectal Cancer Patients. J Inflamm Res 2020;13:1245-59. [PMID: 33408498 DOI: 10.2147/JIR.S283069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
153 Ribeiro Pereira P, Bertozzi de Aquino Mattos É, Nitzsche Teixeira Fernandes Corrêa AC, Afonso Vericimo M, Margaret Flosi Paschoalin V. Anticancer and Immunomodulatory Benefits of Taro (Colocasia esculenta) Corms, an Underexploited Tuber Crop. Int J Mol Sci 2020;22:E265. [PMID: 33383887 DOI: 10.3390/ijms22010265] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
154 Chen T, Huang Y, Hong J, Wei X, Zeng F, Li J, Ye G, Yuan J, Long Y. Preparation, COX-2 Inhibition and Anticancer Activity of Sclerotiorin Derivatives. Mar Drugs 2020;19:12. [PMID: 33383842 DOI: 10.3390/md19010012] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
155 Sabran A, Kumolosasi E, Jantan I, Jamal JA, Azmi N, Jasamai M. Induction of cell death and modulation of Annexin A1 by phytoestrogens in human leukemic cell lines. Saudi Pharm J 2021;29:73-84. [PMID: 33603542 DOI: 10.1016/j.jsps.2020.12.011] [Reference Citation Analysis]
156 Monteleone NJ, Lutz CS. miR-708-5p enhances erlotinib/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells. Oncotarget 2020;11:4699-721. [PMID: 33473256 DOI: 10.18632/oncotarget.27840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Kharkar PS. Cancer Stem Cell (CSC) Inhibitors in Oncology-A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives. J Med Chem 2020;63:15279-307. [PMID: 33325699 DOI: 10.1021/acs.jmedchem.0c01336] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
158 Theil G, Fornara P, Bialek J. Position of Circulating Tumor Cells in the Clinical Routine in Prostate Cancer and Breast Cancer Patients. Cancers (Basel) 2020;12:E3782. [PMID: 33333999 DOI: 10.3390/cancers12123782] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
159 Anunciato Casarini TP, Frank LA, Pohlmann AR, Guterres SS. Dermatological applications of the flavonoid phloretin. Eur J Pharmacol 2020;889:173593. [PMID: 32971088 DOI: 10.1016/j.ejphar.2020.173593] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
160 Parvathareddy SK, Siraj AK, Annaiyappanaidu P, Al-Sobhi SS, Al-Dayel F, Al-Kuraya KS. Prognostic Significance of COX-2 Overexpression in BRAF-Mutated Middle Eastern Papillary Thyroid Carcinoma. Int J Mol Sci 2020;21:E9498. [PMID: 33327467 DOI: 10.3390/ijms21249498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
161 Yan C, Zhang C, Cao X, Feng B, Li X. Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its Derivatives. Molecules 2020;25:E5857. [PMID: 33322383 DOI: 10.3390/molecules25245857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
162 Hsu MY, Mina E, Roetto A, Porporato PE. Iron: An Essential Element of Cancer Metabolism. Cells 2020;9:E2591. [PMID: 33287315 DOI: 10.3390/cells9122591] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
163 Frejborg E, Salo T, Salem A. Role of Cyclooxygenase-2 in Head and Neck Tumorigenesis. Int J Mol Sci 2020;21:E9246. [PMID: 33287464 DOI: 10.3390/ijms21239246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
164 Nada HG, Sudha T, Darwish NH, Mousa SA. Lactobacillus acidophilus and Bifidobacterium longum exhibit antiproliferation, anti-angiogenesis of gastric and bladder cancer: Impact of COX2 inhibition. PharmaNutrition 2020;14:100219. [DOI: 10.1016/j.phanu.2020.100219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Yin Z, Guo H, Jiang K, Ou J, Wang M, Huang C, Liu F, Bai W, Zheng J, Ou S. Morin decreases acrolein-induced cell injury in normal human hepatocyte cell line LO2. Journal of Functional Foods 2020;75:104234. [DOI: 10.1016/j.jff.2020.104234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Finetti F, Biagi M, Ercoli J, Macrì G, Miraldi E, Trabalzini L. Phaseolus vulgaris L. var. Venanzio Grown in Tuscany: Chemical Composition and In Vitro Investigation of Potential Effects on Colorectal Cancer. Antioxidants (Basel) 2020;9:E1181. [PMID: 33256057 DOI: 10.3390/antiox9121181] [Reference Citation Analysis]
167 Moayyedi P, El-Serag HB. Current Status of Chemoprevention in Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:117-30. [PMID: 33213791 DOI: 10.1016/j.giec.2020.08.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Chen J, Huang J. Sorafenib delivered by cancer cell membrane remodels tumor microenvironment to enhances the immunotherapy of mitoxantrone in breast cancer. J Mater Res 2020;35:3296-303. [DOI: 10.1557/jmr.2020.321] [Reference Citation Analysis]
169 Badalanloo K, Naji T, Ahmadi R. Cytotoxic and Apoptotic Effects of Celecoxib and Topotecan on AGS and HEK 293 Cell Lines. J Gastrointest Cancer 2020. [PMID: 33200341 DOI: 10.1007/s12029-020-00434-8] [Reference Citation Analysis]
170 Xie J, Luo FX, Shi CY, Jiang WW, Qian YY, Yang MR, Song S, Dai TY, Peng L, Gao XY, Tao L, Tian Y, Sheng J. Moringa oleifera Alkaloids Inhibited PC3 Cells Growth and Migration Through the COX-2 Mediated Wnt/β-Catenin Signaling Pathway. Front Pharmacol 2020;11:523962. [PMID: 33343339 DOI: 10.3389/fphar.2020.523962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Husain K, Williamson TT, Nelson N, Ghansah T. Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer. Immunol Med 2020;:1-16. [PMID: 33164702 DOI: 10.1080/25785826.2020.1843267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
172 Memariani Z, Abbas SQ, Ul Hassan SS, Ahmadi A, Chabra A. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review. Pharmacol Res 2021;171:105264. [PMID: 33166734 DOI: 10.1016/j.phrs.2020.105264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
173 Chiavari M, Ciotti GMP, Canonico F, Altieri F, Lacal PM, Graziani G, Navarra P, Lisi L. PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation. Int J Mol Sci 2020;21:E8214. [PMID: 33153019 DOI: 10.3390/ijms21218214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
174 Prasher P, Sharma M. "Azole" as privileged heterocycle for targeting the inducible cyclooxygenase enzyme. Drug Dev Res 2021;82:167-97. [PMID: 33137216 DOI: 10.1002/ddr.21753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
175 Soares CD, Hernandez-Guerrero JC, Andrade BA, Romañach MJ, Mosqueda-Taylor A, Carlos R, Macedo MR, Almeida OP, Jorge J. Comparative expression of cyclooxygenase 2 and Ki67 in amelanotic and conventional oral melanomas. Med Oral Patol Oral Cir Bucal 2020;25:e728-31. [PMID: 32388516 DOI: 10.4317/medoral.23737] [Reference Citation Analysis]
176 Leto G, Flandina C, Crescimanno M, Giammanco M, Sepporta MV. Effects of oleuropein on tumor cell growth and bone remodelling: Potential clinical implications for the prevention and treatment of malignant bone diseases. Life Sci 2021;264:118694. [PMID: 33130080 DOI: 10.1016/j.lfs.2020.118694] [Reference Citation Analysis]
177 Hwang ST, Yang MH, Baek SH, Um JY, Ahn KS. Genistin attenuates cellular growth and promotes apoptotic cell death breast cancer cells through modulation of ERalpha signaling pathway. Life Sci 2020;263:118594. [PMID: 33075375 DOI: 10.1016/j.lfs.2020.118594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Lopes C, Pereira C, Farinha M, Medeiros R, Dinis-Ribeiro M. Prostaglandin E2 Pathway Is Dysregulated in Gastric Adenocarcinoma in a Caucasian Population. Int J Mol Sci 2020;21:E7680. [PMID: 33081378 DOI: 10.3390/ijms21207680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
179 Jin S, Muhammad N, Sun Y, Tan Y, Yuan H, Song D, Guo Z, Wang X. Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX‐2 and PD‐L1. Angew Chem 2020;132:23513-21. [DOI: 10.1002/ange.202011273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
180 Ashrafizadeh M, Bakhoda MR, Bahmanpour Z, Ilkhani K, Zarrabi A, Makvandi P, Khan H, Mazaheri S, Darvish M, Mirzaei H. Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Front Chem 2020;8:829. [PMID: 33195038 DOI: 10.3389/fchem.2020.00829] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
181 Jin S, Muhammad N, Sun Y, Tan Y, Yuan H, Song D, Guo Z, Wang X. Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX-2 and PD-L1. Angew Chem Int Ed Engl 2020;59:23313-21. [PMID: 32897000 DOI: 10.1002/anie.202011273] [Cited by in Crossref: 12] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
182 Burke L, Guterman I, Palacios Gallego R, Britton RG, Burschowsky D, Tufarelli C, Rufini A. The Janus-like role of proline metabolism in cancer. Cell Death Discov 2020;6:104. [PMID: 33083024 DOI: 10.1038/s41420-020-00341-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
183 Malerba P, Crews BC, Ghebreselasie K, Daniel CK, Jashim E, Aleem AM, Salam RA, Marnett LJ, Uddin MJ. Targeted Detection of Cyclooxygenase-1 in Ovarian Cancer. ACS Med Chem Lett 2020;11:1837-42. [PMID: 33062161 DOI: 10.1021/acsmedchemlett.9b00280] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
184 Akhtar W, Marella A, Alam MM, Khan MF, Akhtar M, Anwer T, Khan F, Naematullah M, Azam F, Rizvi MA, Shaquiquzzaman M. Design and synthesis of pyrazole-pyrazoline hybrids as cancer-associated selective COX-2 inhibitors. Arch Pharm (Weinheim) 2021;354:e2000116. [PMID: 33015829 DOI: 10.1002/ardp.202000116] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
185 Vergani E, Dugo M, Cossa M, Frigerio S, Di Guardo L, Gallino G, Mattavelli I, Vergani B, Lalli L, Tamborini E, Valeri B, Gargiuli C, Shahaj E, Ferrarini M, Ferrero E, Gomez Lira M, Huber V, Vecchio MD, Sensi M, Leone BE, Santinami M, Rivoltini L, Rodolfo M, Vallacchi V. miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators. Cell Commun Signal 2020;18:156. [PMID: 32967672 DOI: 10.1186/s12964-020-00601-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
186 Weiße J, Rosemann J, Krauspe V, Kappler M, Eckert AW, Haemmerle M, Gutschner T. RNA-Binding Proteins as Regulators of Migration, Invasion and Metastasis in Oral Squamous Cell Carcinoma. Int J Mol Sci 2020;21:E6835. [PMID: 32957697 DOI: 10.3390/ijms21186835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
187 Barboza JR, Pereira FAN, Fernandes RA, Vasconcelos CC, Cartágenes MDSS, Oliveira Lopes AJ, Melo AC, Guimarães IDS, Rocha CQD, Ribeiro MNS. Cytotoxicity and Pro-Apoptotic, Antioxidant and Anti-Inflammatory Activities of Geopropolis Produced by the Stingless Bee Melipona fasciculata Smith. Biology (Basel) 2020;9:E292. [PMID: 32942772 DOI: 10.3390/biology9090292] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Hu JW, Chen B, Zhang J, Qi YP, Liang JH, Zhong JH, Xiang BD. Novel combination of celecoxib and metformin improves the antitumor effect by inhibiting the growth of Hepatocellular Carcinoma. J Cancer 2020;11:6437-44. [PMID: 33033527 DOI: 10.7150/jca.47532] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
189 Sawasdikosol S, Burakoff S. A perspective on HPK1 as a novel immuno-oncology drug target. Elife 2020;9:e55122. [PMID: 32896273 DOI: 10.7554/eLife.55122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
190 Zhang L, Wu Y, Wu J, Zhou M, Li D, Wan X, Jin F, Wang Y, Lin W, Zha X, Liu Y. KLF5-mediated COX2 upregulation contributes to tumorigenesis driven by PTEN deficiency. Cell Signal 2020;75:109767. [PMID: 32890667 DOI: 10.1016/j.cellsig.2020.109767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
191 Kuźbicki Ł, Brożyna AA. Expression of Cyclooxygenase-2 in Human Epithelial Skin Lesions: A Systematic Review of Immunohistochemical Studies. Appl Immunohistochem Mol Morphol 2021;29:163-74. [PMID: 32889812 DOI: 10.1097/PAI.0000000000000871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Pathak G, Singh S, Kumari P, Hussain Y, Raza W, Luqman S, Meena A. Cirsilineol inhibits proliferation of lung squamous cell carcinoma by inducing ROS mediated apoptosis. Food and Chemical Toxicology 2020;143:111550. [DOI: 10.1016/j.fct.2020.111550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
193 Hatano K, Fujita K, Nonomura N. Application of Anti-Inflammatory Agents in Prostate Cancer. J Clin Med 2020;9:E2680. [PMID: 32824865 DOI: 10.3390/jcm9082680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
194 Zárate LV, Pontillo CA, Español A, Miret NV, Chiappini F, Cocca C, Álvarez L, de Pisarev DK, Sales ME, Randi AS. Angiogenesis signaling in breast cancer models is induced by hexachlorobenzene and chlorpyrifos, pesticide ligands of the aryl hydrocarbon receptor. Toxicol Appl Pharmacol 2020;401:115093. [PMID: 32526215 DOI: 10.1016/j.taap.2020.115093] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
195 Hermanowicz JM, Kwiatkowska I, Pawlak D. Important players in carcinogenesis as potential targets in cancer therapy: an update. Oncotarget 2020;11:3078-101. [PMID: 32850012 DOI: 10.18632/oncotarget.27689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
196 Ercoli J, Finetti F, Woodby B, Belmonte G, Miracco C, Valacchi G, Trabalzini L. KRIT1 as a possible new player in melanoma aggressiveness. Arch Biochem Biophys 2020;691:108483. [PMID: 32735866 DOI: 10.1016/j.abb.2020.108483] [Reference Citation Analysis]
197 Kazberuk A, Zareba I, Palka J, Surazynski A. A novel plausible mechanism of NSAIDs-induced apoptosis in cancer cells: the implication of proline oxidase and peroxisome proliferator-activated receptor. Pharmacol Rep 2020;72:1152-60. [PMID: 32710395 DOI: 10.1007/s43440-020-00140-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
198 Mortezaee K. Immune escape: A critical hallmark in solid tumors. Life Sci 2020;258:118110. [PMID: 32698074 DOI: 10.1016/j.lfs.2020.118110] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
199 Perrot CY, Herrera JL, Fournier-Goss AE, Komatsu M. Prostaglandin E2 breaks down pericyte-endothelial cell interaction via EP1 and EP4-dependent downregulation of pericyte N-cadherin, connexin-43, and R-Ras. Sci Rep 2020;10:11186. [PMID: 32636414 DOI: 10.1038/s41598-020-68019-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
200 Monteleone NJ, Lutz CS. miR-708-5p targets oncogenic prostaglandin E2 production to suppress a pro-tumorigenic phenotype in lung cancer cells. Oncotarget 2020;11:2464-83. [PMID: 32655834 DOI: 10.18632/oncotarget.27614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
201 Mishan MA, Khazeei Tabari MA, Zargari M, Bagheri A. MicroRNAs in the anticancer effects of celecoxib: A systematic review. Eur J Pharmacol 2020;882:173325. [PMID: 32615181 DOI: 10.1016/j.ejphar.2020.173325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
202 Liu J, Yang X, Zhang L, Yang B, Rao W, Li M, Dai N, Yang Y, Qian C, Zhang L, Xiao H, Wang D. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma. J Cancer Res Clin Oncol 2020;146:2299-310. [PMID: 32556504 DOI: 10.1007/s00432-020-03287-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 Chang CY, Pan PH, Li JR, Ou YC, Wang JD, Liao SL, Chen WY, Wang WY, Chen CJ. Aspirin Induced Glioma Apoptosis through Noxa Upregulation. Int J Mol Sci 2020;21:E4219. [PMID: 32545774 DOI: 10.3390/ijms21124219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
204 Reich S, Nguyen CDL, Has C, Steltgens S, Soni H, Coman C, Freyberg M, Bichler A, Seifert N, Conrad D, Knobbe-Thomsen CB, Tews B, Toedt G, Ahrends R, Medenbach J. A multi-omics analysis reveals the unfolded protein response regulon and stress-induced resistance to folate-based antimetabolites. Nat Commun 2020;11:2936. [PMID: 32522993 DOI: 10.1038/s41467-020-16747-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
205 Sharma P, Caldwell TS, Rivera MN, Gullapalli RR. Cadmium exposure activates Akt/ERK Signaling and pro-inflammatory COX-2 expression in human gallbladder epithelial cells via a ROS dependent mechanism. Toxicol In Vitro 2020;67:104912. [PMID: 32512147 DOI: 10.1016/j.tiv.2020.104912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
206 Pandya PN, Kumar SP, Bhadresha K, Patel CN, Patel SK, Rawal RM, Mankad AU. Identification of promising compounds from curry tree with cyclooxygenase inhibitory potential using a combination of machine learning, molecular docking, dynamics simulations and binding free energy calculations. Molecular Simulation 2020;46:812-22. [DOI: 10.1080/08927022.2020.1764552] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
207 Roda E, Luca F, Iorio CD, Ratto D, Siciliani S, Ferrari B, Cobelli F, Borsci G, Priori EC, Chinosi S, Ronchi A, Franco R, Di Francia R, Berretta M, Locatelli CA, Gregori A, Savino E, Bottone MG, Rossi P. Novel Medicinal Mushroom Blend as a Promising Supplement in Integrative Oncology: A Multi-Tiered Study using 4T1 Triple-Negative Mouse Breast Cancer Model. Int J Mol Sci 2020;21:E3479. [PMID: 32423132 DOI: 10.3390/ijms21103479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
208 Pathak G, Singh S, Kumari P, Raza W, Hussain Y, Meena A. Cirsimaritin, a lung squamous carcinoma cells (NCIH-520) proliferation inhibitor. J Biomol Struct Dyn 2021;39:3312-23. [PMID: 32362196 DOI: 10.1080/07391102.2020.1763198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
209 Palumbo P, Lombardi F, Augello FR, Giusti I, Dolo V, Leocata P, Cifone MG, Cinque B. Biological effects of selective COX-2 inhibitor NS398 on human glioblastoma cell lines. Cancer Cell Int 2020;20:167. [PMID: 32435158 DOI: 10.1186/s12935-020-01250-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
210 Hemmat N, Mokhtarzadeh A, Aghazadeh M, Jadidi-Niaragh F, Baradaran B, Bannazadeh Baghi H. Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer. Mol Biol Rep 2020;47:4553-68. [PMID: 32383136 DOI: 10.1007/s11033-020-05494-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
211 Sohraby F, Aryapour H. Rational drug repurposing for cancer by inclusion of the unbiased molecular dynamics simulation in the structure-based virtual screening approach: Challenges and breakthroughs. Semin Cancer Biol 2021;68:249-57. [PMID: 32360530 DOI: 10.1016/j.semcancer.2020.04.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
212 Dhingra AK, Chopra B. Inflammation as a Therapeutic Target for Various Deadly Disorders: A Review. CDT 2020;21:582-8. [DOI: 10.2174/1389450120666191204154115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
213 Ai H, Qin H, Li J, Niu C, Song Z, Bao Y, Sun L, Zheng L, Li Y. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway. Biochem Pharmacol 2020;177:113984. [PMID: 32311348 DOI: 10.1016/j.bcp.2020.113984] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
214 Casadei-Gardini A, Vagheggini A, Gelsomino F, Spallanzani A, Ulivi P, Orsi G, Rovesti G, Andrikou K, Tamburini E, Scartozzi M, Cascinu S. Is There an Optimal Choice in Refractory Colorectal Cancer? A Network Meta-Analysis. Clin Colorectal Cancer 2020;19:82-90.e9. [PMID: 32192883 DOI: 10.1016/j.clcc.2019.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Kuźmycz O, Stączek P. Prospects of NSAIDs administration as double-edged agents against endometrial cancer and pathological species of the uterine microbiome. Cancer Biol Ther 2020;21:486-94. [PMID: 32174282 DOI: 10.1080/15384047.2020.1736483] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
216 Shao W, Kuhn C, Mayr D, Ditsch N, Kailuwait M, Wolf V, Harbeck N, Mahner S, Jeschke U, Cavaillès V, Sixou S. Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers. J Transl Med 2020;18:94. [PMID: 32085795 DOI: 10.1186/s12967-020-02271-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
217 George S, Lucero Y, Torres JP, Lagomarcino AJ, O'Ryan M. Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children. Front Microbiol 2020;11:90. [PMID: 32117120 DOI: 10.3389/fmicb.2020.00090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
218 Lee R, Choi YJ, Jeong MS, Park YI, Motoyama K, Kim MW, Kwon S, Choi JH. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer. Bioconjugate Chem 2020;31:923-32. [DOI: 10.1021/acs.bioconjchem.0c00048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
219 Kurz M, Krett A, Bünemann M. Voltage Dependence of Prostanoid Receptors. Mol Pharmacol 2020;97:267-77. [DOI: 10.1124/mol.119.118372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Obradović A, Matić M, Ognjanović B, Đurđević P, Marinković E, Ušćumlić G, Božić B, Božić Nedeljković B. Antiproliferative and antimigratory effects of 3-(4-substituted benzyl)-5- isopropyl-5-phenylhydantoin derivatives in human breast cancer cells. Saudi Pharm J 2020;28:246-54. [PMID: 32194325 DOI: 10.1016/j.jsps.2020.01.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
221 Knapp DW, Dhawan D, Ramos-Vara JA, Ratliff TL, Cresswell GM, Utturkar S, Sommer BC, Fulkerson CM, Hahn NM. Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans. Front Oncol 2019;9:1493. [PMID: 32039002 DOI: 10.3389/fonc.2019.01493] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
222 Fiorito V, Chiabrando D, Petrillo S, Bertino F, Tolosano E. The Multifaceted Role of Heme in Cancer. Front Oncol 2019;9:1540. [PMID: 32010627 DOI: 10.3389/fonc.2019.01540] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
223 Feng S, Pan J, Li C, Zheng Y. Folic acid-conjugated nitrogen-doped graphene quantum dots as a fluorescent diagnostic material for MCF-7 cells. Nanotechnology 2020;31:135701. [DOI: 10.1088/1361-6528/ab5f7f] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
224 Yamahana H, Takino T, Endo Y, Yamada H, Suzuki T, Uto Y. A novel celecoxib analog UTX-121 inhibits HT1080 cell invasion by modulating membrane-type 1 matrix metalloproteinase. Biochemical and Biophysical Research Communications 2020;521:137-44. [DOI: 10.1016/j.bbrc.2019.10.092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Werner M, Pace S, Czapka A, Jordan PM, Gerstmeier J, Koeberle A, Werz O. Communication between human macrophages and epithelial cancer cell lines dictates lipid mediator biosynthesis. Cell Mol Life Sci 2020;77:4365-78. [PMID: 31894359 DOI: 10.1007/s00018-019-03413-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
226 Aslan A, Hussein YT, Gok O, Beyaz S, Erman O, Baspinar S. Ellagic acid ameliorates lung damage in rats via modulating antioxidant activities, inhibitory effects on inflammatory mediators and apoptosis-inducing activities. Environ Sci Pollut Res Int 2020;27:7526-37. [PMID: 31885062 DOI: 10.1007/s11356-019-07352-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
227 Yamaguchi I, Nakajima K, Shono K, Mizobuchi Y, Fujihara T, Shikata E, Yamaguchi T, Kitazato K, Sampetrean O, Saya H, Takagi Y. Downregulation of PD-L1 via FKBP5 by celecoxib augments antitumor effects of PD-1 blockade in a malignant glioma model. Neurooncol Adv 2020;2:vdz058. [PMID: 32642723 DOI: 10.1093/noajnl/vdz058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
228 Lu H, Zhu G, Tang T, Ma Z, Chen Q, Chen Z. Anticancer Molecule Discovery via C2-Substituent Promoted Oxidative Coupling of Indole and Enolate. iScience 2019;22:214-28. [PMID: 31786518 DOI: 10.1016/j.isci.2019.11.021] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
229 Omene C, Ma L, Moore J, Ouyang H, Illa-Bochaca I, Chou W, Patel MS, Sebastiano C, Demaria S, Mao JH, Karagoz K, Gatza ML, Barcellos-Hoff MH. Aggressive Mammary Cancers Lacking Lymphocytic Infiltration Arise in Irradiated Mice and Can Be Prevented by Dietary Intervention. Cancer Immunol Res 2020;8:217-29. [PMID: 31831632 DOI: 10.1158/2326-6066.CIR-19-0253] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
230 Ashrafizadeh M, Tavakol S, Ahmadi Z, Roomiani S, Mohammadinejad R, Samarghandian S. Therapeutic effects of kaempferol affecting autophagy and endoplasmic reticulum stress. Phytother Res 2020;34:911-23. [PMID: 31829475 DOI: 10.1002/ptr.6577] [Cited by in Crossref: 13] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
231 Opitz CA, Somarribas Patterson LF, Mohapatra SR, Dewi DL, Sadik A, Platten M, Trump S. The therapeutic potential of targeting tryptophan catabolism in cancer. Br J Cancer 2020;122:30-44. [PMID: 31819194 DOI: 10.1038/s41416-019-0664-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 87] [Article Influence: 16.7] [Reference Citation Analysis]
232 Ercolano G, De Cicco P, Rubino V, Terrazzano G, Ruggiero G, Carriero R, Kunderfranco P, Ianaro A. Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment. Front Pharmacol 2019;10:1456. [PMID: 31920649 DOI: 10.3389/fphar.2019.01456] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
233 El-sayed NA, Nour MS, Salem MA, Arafa RK. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies. European Journal of Medicinal Chemistry 2019;183:111693. [DOI: 10.1016/j.ejmech.2019.111693] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
234 Kuźbicki Ł, Brożyna AA. Immunohistochemical detectability of cyclooxygenase-2 expression in cells of human melanocytic skin lesions: A methodological review. J Cutan Pathol 2020;47:363-80. [PMID: 31675116 DOI: 10.1111/cup.13606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
235 Gruszka AM, Valli D, Alcalay M. Wnt Signalling in Acute Myeloid Leukaemia. Cells 2019;8:E1403. [PMID: 31703382 DOI: 10.3390/cells8111403] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
236 Ghazizadeh Darband S, Saboory E, Sadighparvar S, Kaviani M, Mobaraki K, Jabbari N, Majidinia M. The modulatory effects of exercise on the inflammatory and apoptotic markers in rats with 1,2-dimethylhydrazine-induced colorectal cancer. Can J Physiol Pharmacol 2020;98:147-55. [PMID: 31614098 DOI: 10.1139/cjpp-2019-0329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
237 Tan L, Wang Y, Ai G, Luo C, Chen H, Li C, Zeng H, Xie J, Chen J, Su Z. Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways. International Immunopharmacology 2019;75:105802. [DOI: 10.1016/j.intimp.2019.105802] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
238 Lee JH, Rangappa S, Mohan CD, Sethi G, Lin ZX, Rangappa KS, Ahn KS; Basappa. Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma. Biomolecules 2019;9:E550. [PMID: 31575007 DOI: 10.3390/biom9100550] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
239 Dai H, Zhang S, Ma R, Pan L. Celecoxib Inhibits Hepatocellular Carcinoma Cell Growth and Migration by Targeting PNO1. Med Sci Monit 2019;25:7351-60. [PMID: 31568401 DOI: 10.12659/MSM.919218] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
240 Cai Y, Yousef A, Grandis JR, Johnson DE. NSAID therapy for PIK3CA-Altered colorectal, breast, and head and neck cancer. Adv Biol Regul 2020;75:100653. [PMID: 31594701 DOI: 10.1016/j.jbior.2019.100653] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
241 Dong H, Wang K, Chang X, Jin F, Wang Q, Jiang X, Liu J, Wu Y, Yang C. Beta-ionone-inhibited proliferation of breast cancer cells by inhibited COX-2 activity. Arch Toxicol 2019;93:2993-3003. [DOI: 10.1007/s00204-019-02550-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
242 Qi YF, Liu M, Zhang Y, Liu W, Xiao H, Luo B. EBV down-regulates COX-2 expression via TRAF2 and ERK signal pathway in EBV-associated gastric cancer. Virus Res 2019;272:197735. [PMID: 31473273 DOI: 10.1016/j.virusres.2019.197735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
243 Kisková T, Kassayová M. Resveratrol Action on Lipid Metabolism in Cancer. Int J Mol Sci 2019;20:E2704. [PMID: 31159437 DOI: 10.3390/ijms20112704] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
244 Ullrich M, Richter S, Seifert V, Hauser S, Calsina B, Martínez-Montes ÁM, Ter Laak M, Ziegler CG, Timmers H, Eisenhofer G, Robledo M, Pietzsch J. Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background. Cancers (Basel) 2019;11:E743. [PMID: 31142060 DOI: 10.3390/cancers11060743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
245 Nogueira KM, de Souza LKM, de Oliveira AP, Pacheco G, Iles B, Alencar MS, Nicolau LAD, Silva RO, da Nóbrega FR, Sousa DP, de Souza MHLP, Medeiros JVR. Efficacy of a phenol derivative, isopropyl vanillate, as an anti-inflammatory agent: A new small molecule inhibitor of COX and neutrophil migration. Drug Dev Res 2019;80:666-79. [PMID: 31112325 DOI: 10.1002/ddr.21546] [Reference Citation Analysis]
246 Mazzoni M, Mauro G, Erreni M, Romeo P, Minna E, Vizioli MG, Belgiovine C, Rizzetti MG, Pagliardini S, Avigni R, Anania MC, Allavena P, Borrello MG, Greco A. Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism. J Exp Clin Cancer Res 2019;38:208. [PMID: 31113465 DOI: 10.1186/s13046-019-1198-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 6.7] [Reference Citation Analysis]
247 Casadei-Gardini A, Scarpi E, Ulivi P, Palladino MA, Accettura C, Bernardini I, Spallanzani A, Gelsomino F, Corbelli J, Marisi G, Ruscelli S, Valgiusti M, Frassineti GL, Passardi A. Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study. Cancer Manag Res 2019;11:4357-69. [PMID: 31191000 DOI: 10.2147/CMAR.S198651] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
248 Tavares WR, Seca AML. Inula L. Secondary Metabolites against Oxidative Stress-Related Human Diseases. Antioxidants (Basel) 2019;8:E122. [PMID: 31064136 DOI: 10.3390/antiox8050122] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
249 Monteleone NJ, Moore AE, Iacona JR, Lutz CS, Dixon DA. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer. Sci Rep 2019;9:5405. [PMID: 30931980 DOI: 10.1038/s41598-019-41862-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
250 Destefanis F, Fiorito V, Altruda F, Tolosano E. Investigating the Connection Between Endogenous Heme Accumulation and COX2 Activity in Cancer Cells. Front Oncol 2019;9:162. [PMID: 30941311 DOI: 10.3389/fonc.2019.00162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
251 Wallace TR, Tarullo SE, Crump LS, Lyons TR. Studies of postpartum mammary gland involution reveal novel pro-metastatic mechanisms. J Cancer Metastasis Treat 2019;5:9. [PMID: 30847405 DOI: 10.20517/2394-4722.2019.01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
252 Jeucken A, Brouwers JF. High-Throughput Screening of Lipidomic Adaptations in Cultured Cells. Biomolecules 2019;9:E42. [PMID: 30682837 DOI: 10.3390/biom9020042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
253 Fuller B. Role of PGE-2 and Other Inflammatory Mediators in Skin Aging and Their Inhibition by Topical Natural Anti-Inflammatories. Cosmetics 2019;6:6. [DOI: 10.3390/cosmetics6010006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
254 Baecker D, Obermoser V, Kirchner EA, Hupfauf A, Kircher B, Gust R. Fluorination as tool to improve bioanalytical sensitivity and COX-2-selective antitumor activity of cobalt alkyne complexes. Dalton Trans 2019;48:15856-68. [DOI: 10.1039/c9dt03330k] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
255 Ahmadi A, Najafi M, Farhood B, Mortezaee K. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy. J Cell Physiol 2019;234:12173-87. [PMID: 30537043 DOI: 10.1002/jcp.27955] [Cited by in Crossref: 56] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]